Topic:











Programme Phase:



Content Format:









Topic 6.2, :

What about biological therapy?

M. Ferrante

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.3 :

When approved drugs dont work

D. Wilson

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.4 :

5-ASA compounds

G. Rogler

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.4 :

Anti-TNF agents

F. Baert

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.4 :

Methotrexate

P. Juillerat

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.4 :

Steroids

S. Vavricka

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.4 :

Thiopurines

P. Irving

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.4 :

Ustekinumab

M. Ferrante

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.4 :

Vedolizumab

J. Lindsay

ECCO'18 Vienna

PPT
 


Topic 6.2, 6.5 :

Interpreting blood results (TGN, IGRA, TNF levels abnormal LFT, importance of TDM)

P. Irving

ECCO'18 Vienna

Webcast + PPT